Retinoic acid reduces solvent-induced neuropathy and promotes neural regeneration in mice

Journal of Neuroscience Research

Volumn 92, Issue 8, 2014, Pages 1062-1070

  Palencia, Guadalupe ^a   Hernández Pedro, Norma ^b   Saavedra Perez, David ^b   Peña Curiel, Omar ^b   Ortiz Plata, Alma ^a   Ordoñez, Graciela ^a   Flores Estrada, Diana ^b   Sotelo, Julio ^a,c   Arrieta, Oscar ^b,c  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

All trans retinoic acid treatment; Nerve growth factor; Neural regeneration; Organic solvent exposure; Peripheral neuropathy

Indexed keywords

RETINOIC ACID; SOLVENT; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; LATENT PERIOD; MALE; MOUSE; NERVE FIBER DEGENERATION; NERVE REGENERATION; NONHUMAN; NONMYELINATED NERVE; PAIN THRESHOLD; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCHWANN CELL; SCIATIC NERVE; TAIL IMMERSION TEST; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; PERIPHERAL NERVOUS SYSTEM DISEASES;

ANIMALS; MICE; NERVE GROWTH FACTOR; NERVE REGENERATION; PAIN THRESHOLD; PERIPHERAL NERVOUS SYSTEM DISEASES; SCIATIC NERVE; SOLVENTS; TRETINOIN;

EID: 84902551331     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23376     Document Type: Article

References (31)

1. Aloe L, Manni L, Properzi F, De Santis S, Fiore M. 2000. Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis. Auton Neurosci 86:84-93.
2. Althaus JS, Andrus PK, Williams CM, VonVoigtlander PF, Cazers AR, Hall ED. 1993. The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Reversal by tirilazad mesylate (U-74006F). Mol Chem Neuropathol 20:147-162.
3. Apfel SC, Arezzo JC, Lipson L, Kessler JA. 1992. Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 31:76-80.
4. Arrieta O, Garcia-Navarrete R, Zuniga S, Ordonez G, Ortiz A, Palencia G, Morales-Espinosa D, Hernandez-Pedro N, Sotelo J. 2005. Retinoic acid increases tissue and plasma contents of nerve growth factor and prevents neuropathy in diabetic mice. Eur J Clin Invest 35:201-207.
5. Arrieta O, Hernández-Pedro N, Fernández González-Aragón MdC, Saavedra-Pérez D, Campos-Parra A, Ríos-Trejo MÁ, Cerón-Lizárraga T, Martínez-Barrera L, Pineda B, Ordóñez G, Ortiz-Plata A, Granados-Soto V, Sotelo J. 2011. Retinoic acid reduces chemotherapy-induced neuropathy in animal model and lung cancer patients. Neurology 77:987-989.
6. Baelum J. 1991. Human solvent exposure. Factors influencing the pharmacokinetics and acute toxicity. Pharmacol Toxicol 68(Suppl 1):1-36.
7. Baydas G, Reiter RJ, Nedzvetskii VS, Yasar A, Tuzcu M, Ozveren F, Canatan H. 2003. Melatonin protects the central nervous system of rats against toluene-containing thinner intoxication by reducing reactive gliosis. Toxicol Lett 137:169-174.
8. Burmistrov SO, Arutyunyan AV, Stepanov MG, Oparina TI, Prokopenko VM. 2001. Effect of chronic inhalation of toluene and dioxane on activity of free radical processes in rat ovaries and brain. Bull Exp Biol Med 132:832-836.
9. Carabez A, Sandoval F, Palma L. 1998. Ultrastructural changes of tissues produced by inhalation of thinner in rats. Microsc Res Techniq 40:56-62.
10. Chentanez V, Thanomsridejchai N, Duangmardphon N, Agthong S, Kaewsema A, Huanmanop T, Maneesri S. 2009. Ganglioside GM1 (porcine) ameliorates paclitaxel-induced neuropathy in rats. J Med Assoc Thai 92:50-57.
11. Corcoran J, Maden M. 1999. Nerve growth factor acts via retinoic acid synthesis to stimulate neurite outgrowth. Nat Neurosci 2:307-308.
12. Damasceno BP, de Capitani EM. 1994. Cerebellar atrophy related to chronic exposure to toluene. Case report. Arq Neuropsiquiatr 52:90-92.
13. Dick FD. 2006. Solvent neurotoxicity. Occup Environ Med 63:179, 221-226.
14. Halifeoglu I, Canatan H, Ustundag B, Ilhan N, Inanc F. 2000. Effect of thinner inhalation on lipid peroxidation and some antioxidant enzymes of people working with paint thinner. Cell Biochem Funct 18:263-267.
15. Hayakawa K, Itoh T, Niwa H, Mutoh T, Sobue G. 1998. NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedule: in vitro study of adult rat sympathetic ganglion explants. Brain Res 794:313-319.
16. Hernandez-Pedro N, Ordonez G, Ortiz-Plata A, Palencia-Hernandez G, Garcia-Ulloa AC, Flores-Estrada D, Sotelo J, Arrieta O. 2008. All-trans retinoic acid induces nerve regeneration and increases serum and nerve contents of neural growth factor in experimental diabetic neuropathy. Transl Res 152:31-37.
17. Jacobs JM, Love S. 1985. Qualitative and quantitative morphology of human sural nerve at different ages. Brain 108:897-924.
18. Juntunen J, Hernberg S, Eistola P, Hupli V. 1980. Exposure to industrial solvents and brain atrophy. A retrospective study of pneumoencephalographic findings among 37 patients with exposure to industrial solvents. Eur Neurol 19:366-375.
19. Kallenborn-Gerhardt W, Schroder K, Del Turco D, Lu R, Kynast K, Kosowski J, Niederberger E, Shah AM, Brandes RP, Geisslinger G, Schmidtko A. 2012. NADPH oxidase-4 maintains neuropathic pain after peripheral nerve injury. J Neurosci 32:10136-10145.
20. Khalil Z, Liu T, Helme RD. 1999. Free radicals contribute to the reduction in peripheral vascular responses and the maintenance of thermal hyperalgesia in rats with chronic constriction injury. Pain 79:31-37.
21. Mattia CJ, Ali SF, Bondy SC. 1993. Toluene-induced oxidative stress in several brain regions and other organs. Mol Chem Neuropathol 18:313-328.
22. National Institutes of Health, NIDA. 2005. Inhalant abuse among children and adolescents: consultation on building an international research agenda. Bethesda, MD: NIH.
23. Ordonez G, Fernandez A, Perez R, Sotelo J. 1994. Low contents of nerve growth factor in serum and submaxillary gland of diabetic mice. A possible etiological element of diabetic neuropathy. J Neurol Sci 121:163-166.
24. Ortiz MA, Bayon Y, Lopez-Hernandez FJ, Piedrafita FJ. 2002. Retinoids in combination therapies for the treatment of cancer: mechanisms and perspectives. Drug Resist Updat 5:162-175.
25. Seppalainen AM. 1985. Neurophysiological aspects of the toxicity of organic solvents. Scand J Work Environ Health 11(Suppl 1):61-64.
26. Wright DE, Ryals JM, McCarson KE, Christianson JA. 2004. Diabetes-induced expression of activating transcription factor 3 in mouse primary sensory neurons. J Peripher Nerv Syst 9:242-254.
27. Yamada K. 1993. Influence of lacquer thinner and some organic solvents on reproductive and accessory reproductive organs in the male rat. Biol Pharm Bull 16:425-427.
28. Yamanouchi N, Okada S, Kodama K, Hirai S, Sekine H, Murakami A, Komatsu N, Sakamoto T, Sato T. 1995. White matter changes caused by chronic solvent abuse. Am J Neuroradiol 16:1643-1649.
29. Zaidi SA, Shaw AN, Patel MN, Shah VV, Rajendran D, Shah BP, Sinha SN, Gandhi SJ, Saiyed HN. 2007. Multi-organ toxicity and death following acute unintentional inhalation of paint thinner fumes. Clin Toxicol 45:287-289.
30. Zhelyaznik N, Schrage K, McCaffery P, Mey J. 2003. Activation of retinoic acid signalling after sciatic nerve injury: up-regulation of cellular retinoid binding proteins. Eur J Neurosci 18:1033-1040.
31. Zhong D, Zhang D, Song Y. 2008. [The role of all-trans-retinoic acid on the proliferation and differentiation of rat embryonic neural stem cells]. Zhongguo xiu fu chong jian wai ke za zhi=Zhongguo xiufu chongjian waike zazhi (Chin J Repar Reconstruct Surg) 22:206-211.